MetaCap

ANI Pharmaceuticals Insider Trades

NASDAQ: ANIPHealth CareBiotechnology: Pharmaceutical PreparationsUSD

73.89+1.91 (+2.65%)

At close: Oct 9, 4:00 PM ET · Delayed 15 min

After hours: 73.89 0.00%

Last 12 months

Purchases
0 · $0
Sales
34 · $11.30M
Shares bought / sold
0 / 146.71K
Net activity
Net selling $11.3 million

ANI Pharmaceuticals insider activity

Over the last 12 months, ANI Pharmaceuticals insiders reported 49 transactions on SEC Form 4: 0 open-market purchases and 34 sales. Insiders bought $0 and sold $11.3 million worth of stock, for net insider selling of $11.3 million. The largest seller was Lalwani Nikhil, with $5.1 million in reported sales.

The most recent filing shows CAREY STEPHEN P. (SVP & CFO) selling 2,850 shares at $73.00 on Sep 29, 2026. Insider sales are common for compensation, tax and diversification reasons, while open-market purchases are rarer; tracking both helps put ANIP's ownership changes in context.

Summary generated from market data by MetaCap's automated system. Methodology

ANIP insider transactions

ANI Pharmaceuticals insider transactions
DateInsiderTypeSharesValueFiling
Sep 29, 2026CAREY STEPHEN P.SVP & CFOSale2,850$208.05KForm 4
Sep 15, 2026Lalwani NikhilPRESIDENT & CEOSale5,400$383.40KForm 4
Sep 14, 2026Cook MeredithSR. VP, GENERAL COUNSEL & SEC.Sale500$35.40KForm 4
Sep 11, 2026Thoma JeanneDirectorSale1,000$71.53KForm 4
Aug 31, 2026CAREY STEPHEN P.SVP & CFOSale2,850$207.48KForm 4
Aug 25, 2026Lalwani NikhilPRESIDENT & CEOSale5,400$401.22KForm 4
Aug 19, 2026Gosebruch Henry ODirectorAward6,662—Form 4
Aug 13, 2026Cook MeredithSR. VP, GENERAL COUNSEL & SEC.Sale500$37.74KForm 4
Aug 10, 2026Gutwerg OriSVP, GENERICSSale3,162$243.47KForm 4
Jul 29, 2026CAREY STEPHEN P.SVP & CFOSale2,850$231.88KForm 4
Jul 18, 2026Cook MeredithSR. VP, GENERAL COUNSEL & SEC.Tax withholding2,466$195.31KForm 4
Jul 13, 2026Cook MeredithSR. VP, GENERAL COUNSEL & SEC.Sale500$40.92KForm 4
Jul 2, 2026CAREY STEPHEN P.SVP & CFOSale3,313$284.92KForm 4
Jul 2, 2026CAREY STEPHEN P.SVP & CFOOption exercise3,313$164.03KForm 4
Jun 29, 2026CAREY STEPHEN P.SVP & CFOSale2,850$239.74KForm 4
Jun 12, 2026Cook MeredithSR. VP, GENERAL COUNSEL & SEC.Sale500$41.02KForm 4
Jun 8, 2026HAUGHEY THOMASDirectorSale2,000$161.76KForm 4
Jun 5, 2026CAREY STEPHEN P.SVP & CFOSale3,312$264.96KForm 4
Jun 5, 2026CAREY STEPHEN P.SVP & CFOOption exercise3,312$163.98KForm 4
May 21, 2026HAUGHEY THOMASDirectorAward4,357—Form 4
May 21, 2026Leonard Matthew JDirectorAward4,357—Form 4
May 21, 2026Pera Antonio RDirectorAward4,357—Form 4
May 21, 2026TANNENBAUM RENEE PDirectorAward4,357—Form 4
May 21, 2026Thoma JeanneDirectorAward4,357—Form 4
May 13, 2026Cook MeredithSR. VP, GENERAL COUNSEL & SEC.Sale500$39.08KForm 4
May 13, 2026Walsh Patrick DDirectorSale10,000$806.30KForm 4
May 12, 2026Gutwerg OriSVP, GENERICSSale2,772$220.37KForm 4
May 12, 2026Rowland Thomas AndrewSVP, HEAD - ESTABLISHED BRANDSSale459$36.36KForm 4
May 11, 2026Walsh Patrick DDirectorSale3,973$320.82KForm 4
May 11, 2026Lalwani NikhilPRESIDENT & CEOSale55,000$4.27MForm 4
Apr 13, 2026Cook MeredithSR. VP, GENERAL COUNSEL & SEC.Sale500$38.98KForm 4
Mar 13, 2026Cook MeredithSR. VP, GENERAL COUNSEL & SEC.Sale500$36.31KForm 4
Mar 13, 2026Mutz ChristopherHEAD OF RARE DISEASESale3,162$226.53KForm 4
Mar 11, 2026Rowland Thomas AndrewSVP, HEAD - ESTABLISHED BRANDSSale4,772$357.47KForm 4
Mar 9, 2026Mutz ChristopherHEAD OF RARE DISEASESale3,602$267.20KForm 4
Mar 9, 2026Davis KristaSVP, CHIEF HR OFFICERSale5,087$377.10KForm 4
Mar 7, 2026CAREY STEPHEN P.SVP & CFOTax withholding5,150$381.31KForm 4
Mar 7, 2026Mutz ChristopherHEAD OF RARE DISEASETax withholding3,314$245.37KForm 4
Mar 7, 2026Lalwani NikhilPRESIDENT & CEOTax withholding17,060$1.26MForm 4
Mar 7, 2026Gutwerg OriSVP, GENERICSTax withholding3,314$245.37KForm 4
Mar 6, 2026Mutz ChristopherHEAD OF RARE DISEASESale2,121$157.42KForm 4
Mar 6, 2026Davis KristaSVP, CHIEF HR OFFICERSale1,485$111.38KForm 4
Mar 5, 2026CAREY STEPHEN P.SVP & CFOSale4,000$302.24KForm 4
Mar 5, 2026CAREY STEPHEN P.SVP & CFOSale3,312$249.79KForm 4
Mar 5, 2026CAREY STEPHEN P.SVP & CFOOption exercise3,312$163.98KForm 4
Mar 3, 2026Walsh Patrick DDirectorSale6,000$445.38KForm 4
Mar 3, 2026Gutwerg OriSVP, GENERICSSale2,060$157.59KForm 4
Mar 2, 2026Mutz ChristopherHEAD OF RARE DISEASESale417$30.86KForm 4
Feb 26, 2026Shanmugam MuthusamyHEAD OF R&D, COO-NOVITIUM OPSAward11,116$857.60KForm 4

Transaction codes follow SEC Form 4: P = open-market purchase, S = open-market sale, A = grant or award, M = option exercise, F = shares withheld for taxes. About Form 4

Related